Loading
Latest filing published 02 Aug 2017 for Nexvet Biopharma plc, €385k.
Not enough history yet: 0 closed purchases, at least 2 are needed.
This profile gathers the share dealings of Damian T. Lismore in Nexvet Biopharma plc. Between 18 February 2016 and 31 July 2017, the trades on record add up to 10 filings.
On the market, this insider has only ever bought: 1 purchase, €14k in total. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 6 option exercises.
The latest filing, published on 2 August 2017, reports a transaction of €385k in Nexvet Biopharma plc. The last purchase on record was published on 22 February 2016, which is 3,896 days ago. Typically, a trade is published a median of 3 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 of 10 declarations